Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynaecology
Reference44 articles.
1. Poly(ADP-ribose): novel functions for an old molecule;Schreiber;Nat Rev Mol Cell Biol,2006
2. PARP goes transcription;Kraus;Cell,2003
3. Poly(ADP-ribosyl)ation by PARP-1: ‘PAR-laying’ NAD+ into a nuclear signal;Kim;Genes Dev,2005
4. Structure and mechanism of a canonical poly(ADP-ribose) glycohydrolase;Dunstan;Nat Commun,2012
5. The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation;Mueller-Dieckmann;Proc Natl Acad Sci U S A,2006
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer;Frontiers in Oncology;2024-08-02
2. Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study;International Journal of Gynecologic Cancer;2024-07-29
3. Diagnosis and treatment of ovarian cancer in the light of modern molecular genetic achievements;Siberian journal of oncology;2023-11-15
4. A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium;Gynecologic Oncology;2022-07
5. Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review;Gynecologic Oncology;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3